Finished
Can the Prophylactic Administration of Tranexamic Acid Reduce Blood Loss After Robotic-assisted Radical Prostatectomy?
NCT04319614 · University Hospital Hradec Kralove · Updated 9 Nov 2022
- What is being tested
- Tranexamic Acid Injectable Product; Placebos
- For
- Robotic-assisted Radical Prostatectomy
- Kind of study
- Tests a treatment or device on volunteers. Phase 4.
- Who can join
- Ages 18 years to 75 years. About 200 people. The full rules are on the registry page.
- Where
- Czechia
- When
- Starts or started 24 Feb 2020, ends 30 June 2022. Registered 24 March 2020.
- Results
- None posted yet.
In the researchers' words
The prophylactic administration of tranexamic acid reduces blood loss during procedures at high risk of perioperative bleeding. Several studies in neurosurgery, cardiac surgery, and orthopedics confirm this finding. The aim of this study is to evaluate the effect of tranexamic acid on peri-and postoperative blood loss and incidence and severity of postoperative complications. A prospective, double-blind, randomized study is conducted to evaluate the effect on several parameters. Based on pilot study data the investigators decided to include 200 patients in the period from February 2020 to March 2022. The patients will be randomly assigned to study and control groups of 100 patients each. The minimum follow-up will be 3 months.
Sites
- University Hospital Hradec KrálovéHradec Králové, Czechia